¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ

Æ÷½ºÅÍ À¯ÀÇ»çÇ×

9¿ù 30ÀÏ(¸ñ) ¿ÀÀü 9½Ã ÀÌÀü±îÁö Æ÷½ºÅ͸¦ ºÎÂøÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
¿ÀÀü 9½ÃºÎÅÍ "ÃÖ¿ì¼ö Æ÷½ºÅÍ»ó" ½É»ç°¡ ½ÃÀ۵˴ϴÙ.

1. Å© ±â : 63.6cm(°¡·Î) X 93.6cm(¼¼·Î)
2. ¼³Ä¡¹æ¹ý : Final ÇÁ·Î±×·¥Áö¿¡ °ÔÀçµÈ ÃÖÁ¾ Æ÷½ºÅÍ ¹øÈ£¸¦ ¹Ýµå½Ã È®ÀÎÇÑ ÈÄ,
        ÇØ´ç Æ÷½ºÅÍ ÆdzÚÀÇ ÇÏ´Ü°ú »ó´ÜÀ» ¸ÂÃß¾î ºÎÂø ºÎÂøÀç·á´Â °³º°Áغñ
3. Àü½Ã±â°£ : 2010³â 9¿ù 30ÀÏ(¸ñ) ¿ÀÀü 9½Ã ~ 10¿ù 1ÀÏ(Åä) ¿ÀÀü 11½Ã

10¿ù 1ÀÏ(Åä) ¿ÀÀü 11½ÃºÎÅÍ Æ÷½ºÅÍ ÆdzÚÀÌ Ã¶¼öµÇ¿À´Ï ¿ÀÀü 10½Ã~11½Ã »çÀÌ¿¡ Æ÷½ºÅ͸¦ Å»ÂøÇϽñ⠹ٶø´Ï´Ù.

Æ÷½ºÅÍ - Àüü   /    ¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ

[ Æ÷½ºÅÍ - »ý½Ä³»ºÐºñÇÐ ]

Exhibition Hall B
¹øÈ£ ¼º¸í ¼Ò¼Ó Á¦¸ñ
RE1 Àü¿µÀº ¿¬¼¼ÀÇ´ë Epigenetic change induced by reactive oxygen species in endometriosis
RE2 ÃÖÁ¾·Ä ºÎ»êÀÇ´ë The vitrified-thawed blastocyst transfer after artificial shrinkage and assisted hatching is superior to fresh embryo transfer in clinical outcomes
RE3 ½É¾Æ¶ó ¿¬¼¼ÀÇ´ë Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome : the Relationship with Hormonal and Metabolic Characteristics.
RE4 ÃÖÅ¿µ ÁÁÀº¹®È­º´¿ø ÀڱñÙÁ¾ Á¶Á÷¿¡¼­ Hedgehog(Hh) ½ÅÈ£Àü´Þü°è ÀÎÀÚÀÇ ¹ßÇö Áõ°¡
RE5 Á¶¾Æ¶ó ÀÌÈ­ÀÇ´ë ´Ù³¶³­¼ÒÁõÈıº ȯÀÚÀÇ ¿¬·É¿¡ µû¸¥ °í¾Èµå·Î°ÕÇ÷Áõ°ú ´ë»çÁõÈıº À§Çè¿äÀΰúÀÇ »ó°ü¼º¿¡ °üÇÑ ¿¬±¸
RE6 ÀÌ°æÀº ¿¬¼¼ÀÇ´ë Anti-mUllerian hormone in women with polycystic ovary syndrome
RE7 Àü¿µÀº ¿¬¼¼ÀÇ´ë Sarcopenia is related to elevated FSH level in postmenopausal women
RE8 ¼ÛÀ翬 °¡Å縯ÀÇ´ë Turner syndrome¿¡¼­ È£¸£¸óÄ¡·á ÈÄÀÇ BMD º¯È­
RE9 °­ÇõÀç ¿ï»êÀÇ´ë Meloxicam reduces cycle cancellation rate by premature ovulation in patients with diminished ovarian reserve undergoing natural cycle IVF
RE10 ±¸À±Èñ ºÎ»êÀÇ´ë Expression of CD44 in endometrial cells and correlation with adherence to peritoneal mesothelial cells from women with and without endometriosis
RE11 ±è¾Æ¸® ¿ø±¤ÀÇ´ë Endometrial vasculatures on the day of ET and pregnancy outcomes in fresh IVF cycles with GnRH agonist long protocol
RE12 ±è¿ëÁø ¸¶¸®¾Æº´¿ø »ýÁã³­Æ÷ ¹è¾ç Áß ³­ÀÚ ¼º¼÷µµ¿¡ µû¸¥ ¹Ì¼¼¸®º¸ÇÙ»ê ¹ßÇö ¾ç»ó ¿¬±¸
RE13 ±èÀ±¿µ ¼­¿ïÀÇ´ë Àΰ£ ¹è¾ÆÁٱ⼼Æ÷ÀÇ ½É±Ù¼¼Æ÷ ºÐÈ­¿¡ ¹ÌÄ¡´Â ¸¶ÀÌÄÚÇö󽺸¶ Á¦°ÅÁ¦ÀÇ ¿µÇâ
RE14 ±èÁ¤ÈÆ ¿ï»êÀÇ´ë Co-transfer of fresh and collected cryopreserved embryos (COFACCE) obtained in minimal stimulation cycles for low responders.
RE15 ±èÁ¤ÈÆ ¿ï»êÀÇ´ë Effect of histone deacetylase inhibitor on the development of endometriosis and nuclear factor-kappa B activation of endometriotic lesions in an in vivo experimental model.
RE16 ±èÁ¤ÈÆ ¿ï»êÀÇ´ë Pioglitazone treatment decreases follicular fluid levels of TNF- and interleukin-6, and improves ovarian response to FSH and IVF outcome in patients with polycystic ovary syndrome undergoing IVF
RE17 ¹®¼öÇö ºÎ»êÀÇ´ë The inhibitory effect of green tea polyphenol epigallocatechin gallate (EGCG) and curcumin on the inflammation of endometriosis
RE18 ¹®Á¦¿ø ¿ï»êÀÇ´ë Impact of uterine fibroids on uterine hemodynamics and the outcome of in vitro fertilization/intracytoplasmic sperm injection
RE19 ¹ÚÇöÅÂ °í·ÁÀÇ´ë Effects of estradiol on differentiation of subcutaneous and visceral human pre-adipocytes
RE20 ¹ÚÇü¹« Áß¾ÓÀÇ´ë °ñ´Ù°øÁõ ½Ã Cholecalciferol 5600 IU°¡ ÇÔÀ¯µÈ Resedronate (Risenex®) ÁÖ1ȸ Åõ¿© ÈÄ Ç÷ÁߺñŸ¹ÎD ³óµµÀÇ º¯È­¿¡ ´ëÇÑ ´Ù±â°ü ¹«ÀÛÀ§ ´ëÁ¶¿¬±¸
RE21 ¹ÚÇü¹« Áß¾ÓÀÇ´ë Çѱ¹ Æó°æ ¿©¼º¿¡¼­ ½Ä¹°¼º ¿¡½ºÆ®·Î°Õ À̼ÒÇöóº»ÀÇ ¼·Ãë ÇöȲ
RE22 ¾ÈÁØ¿ì ¿ï»êÀÇ´ë Combined administration of GnRH agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for IVF
RE23 ¾ÈÁØ¿ì ¿ï»êÀÇ´ë PIOGLITAZONE TREATMENT DECREASES FOLLICULAR FLUID LEVELS OF TNF-ALPHA AND IL-6, AND IMPROVES OVARIAN RESPONSE TO FSH AND IVF OUTCOME IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME UNDERGOING IVF
RE24 ¿À³ªÁ¤ °üµ¿ÀÇ´ë ¿ù°æ ÁÖ±âÀÇ ±ÔÄ¢¼º°ú Anti-Mullerian HormoneÀÇ ¿¬°ü¼º
RE25 À°Áø¼º °í·ÁÀÇ´ë ´ë»çÁõÈıº°ú °ñ¹Ðµµ¿ÍÀÇ °ü·Ã¼º ºÐ¼®
RE26 À±»óÈ£ µ¿±¹ÀÇ´ë Estrogen receptor dinucleotide repeats and PvuII polymorphisms are associated with idiopathic secondary premature ovarian failure
RE27 À̼®¿ì °¡Å縯ÀÇ´ë Çѱ¹ Æó°æ ÈÄ ¿©¼º¿¡¼­ °»³â±â Áõ»ó°ú ´ë»çÁõÈıº°úÀÇ ¿¬°ü¼º
RE28 À̼º±â °Ç¾çÀÇ´ë Decreased Foxp3+ regulatory T cells in Korean women with idiopathic recurrent pregnancy loss
RE29 À̼º±â °Ç¾çÀÇ´ë Positive correlation between Th17 cells and type1 and type2 cytokine producing T cells in women with idiopathic recurrent pregnancy loss
RE30 À̼º±â °Ç¾çÀÇ´ë No correlation between Th17 cells and levels of T, B and NK cells in women with idiopathic recurrent pregnancy loss
RE31 ÀÌÀº½Ç °¡Å縯ÀÇ´ë Gail ¸ðµ¨À» ÀÌ¿ëÇÑ À¯¹æ¾Ï À§Çèµµ ÃøÁ¤
RE32 ÀÌÁö¿µ ÀÌÈ­ÀÇ´ë Does quantitative calcaneal ultrasound correlate with the bone mineral density defined by dual energy X-ray absorptiometry?
RE33 ÀÌÇý¼± ¿¬¼¼ÀÇ´ë Ç÷Áß Æ丮ƾ ³óµµ°¡ Æó°æ ¿©¼ºÀÇ °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâ
RE34 ÀÌÇýÁØ ¼­¿ïÀÇ´ë µ¿°á-Çص¿ ÈÄ ¹è¾Æ ¹ß´Þ ¿¹ÃøÀ» À§ÇÑ sibling¹è¾Æ ºÐ¼®ÀÇ À¯¿ë¼º
RE35 Á¤½ÅÇý ÀÌÈ­ÀÇ´ë ´Ù³¶³­¼ÒÁõÈıº¿¡¼­ ¼º°ÝÀ¯Çüº° »ó°ü°è¼ö¿¡ °üÇÑ ¿¬±¸
RE36 Á¤ÀÎö °¡Å縯ÀÇ´ë Æó°æ¿©¼º Ä¡¹ÐÀ¯¹æ¿¡¼­ Á¶¿µ¼ú°ú ÃÊÀ½ÆÄÀÇ ¼±º°°Ë»ç·Î¼­ÀÇ À¯¿ë¼º
RE37 Á¶¹«¼º ºÎ»êÀÇ´ë NF-¥êB inhibitor BAY11-7085 suppresses the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in TNF-¥á-stimulated human endometriotic stromal cells
RE38 ÇÇ¿ìÁø ÇѾçÀÇ´ë The transcriptional repressor KLF4 is important for the transition of granulosa cells to luteal cells in the ovary.
RE39 ÇÑ¸í¼® µ¿¾ÆÀÇ´ë The correlation between BPA concentrations and androgen levels
RE40 Je Yeon Lee, M.D ÀÌÈ­ÀÇ´ë To investigate the characteristics and to define the most effective diagnosis and treatment of scar endometriosis resulting from abdominal incision and episiotomy.
RE41 ¹ÚÇöÅÂ °í·ÁÀÇ´ë Ovarian hyper-response to administration of an GnRH-agonist without gonadotropins
RE42 ¿ÀÁ¤Àº °æºÏÀÇ´ë A Case of phenotypic female with 46 XY genotype and unilateral atrophic ovary